Abstract
The present invention relates in general to specific NCR-derived peptides capable of binding to membrane-associated biomolecules of the tumor cells, said biomolecules comprising at least one sulfated polysaccharide. Preferred peptides are about 7 to about 120 amino acids in length and are derived from NKp-44, NKp30 or NKp46.
| Original language | English |
|---|---|
| Patent number | US2007280938 |
| IPC | G01N 33/ 574 A I |
| Priority date | 24/11/04 |
| State | Published - 6 Dec 2007 |